Navigation Links
Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008
Date:2/19/2009

485 512,352 Litigation settlements, net 16,537 (1,171) 16,634 (5,946) ------ ------ ------ ------ Total operating expenses 360,062 1,624,334 1,772,336 2,105,353 ------- --------- --------- --------- Earnings (loss) from operations 34,591 (1,268,236) 297,885 (996,058) Interest expense 92,256 133,383 357,045 200,394 Other (expense) income, net (9,246) (43,863) 11,337 97,060 ------ ------- ------ ------ (Loss) earnings before income taxes and minority interest (66,911) (1,445,482) (47,823) (1,099,392) Income tax (benefit) provision (59,955) (77,632) 137,423 112,823 ------- ------- ------- ------- Loss before minority interest (6,956) (1,367,850) (185,246) (1,212,215) Minority interest income (1,765) (272) (4,031) (2,901) ------ ---- ------ ------ Net loss before preferred dividends (5,191) (1,367,578) (181,215) (1,209,314) Preferred dividends 34,799 15,999 139,035 15,999 ------ ------ ------- ------ Net loss available to common shareholders $(39,990) $(1,383,577) $(320,250) $(1,225,313) ======== =========== ========= =========== Loss per common share: Basic
'/>"/>
SOURCE Mylan Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Mylan Announces Pricing of Tender Offers for its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015
2. Mylan to Host Investor Day on October 3, 2007
3. Mylan Inc. Subsidiary, Dey, L.P., Announces that Perforomist(TM) (Formoterol Fumarate) Inhalation Solution is Now Available for Maintenance Treatment of COPD
4. Mylan Announces Appointment of Steven G. Zylstra as Vice President of Global Corporate Communication and Public Relations
5. Mylan Announces Tentative FDA Approval for Lamotrigine Tablets
6. Mylan Announces Final FDA Approval for Balsalazide Disodium Capsules
7. Mylan Announces Amendment to Bystolic(TM) (Nebivolol) Agreement
8. Mylan Announces Final FDA Approval for Ropinirole Hydrochloride Tablets
9. Mylan Launches First Generic Version of Antihypertensive Sular(R) ER in the United States
10. Mylan Confirms First-to-File Patent Challenge Relating to Lescol(R)
11. Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Jan. 22, 2015  Transwestern | RBJ today announces the firm ... space for Shire a leading biopharmaceutical company, at Two Ledgemont ... RBJ,s Robert Richards , president, and Brian Cohen ... the entire five-floor building at 95 Hayden Ave. ...
(Date:1/22/2015)... Mass (PRWEB) January 21, 2015 Cambridge Semantics, ... Web technology, today announced that 2014 was a record-breaking year ... the capabilities of the Anzo Smart Data Platform and our ... and utilize insights from diverse data which led to record ...
(Date:1/22/2015)... January 22, 2015 Crystal Diagnostics (CDx) Xpress ... it has received AOAC-PTM Certifications for the six non-O157 Shiga ... O145; collectively referred to as STEC or the “Big-6”) as ... forming unit (cfu) per 325 g of raw ground beef ...
(Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently was invited to ... on probiotics in San Diego, CA. , The Scripps ... health care professionals. This year’s pre-conference seminar was held on ... Dr. Leyer spoke about the emerging topics and science in ...
Breaking Biology Technology:Transwestern | RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Cambridge Semantics Announces Record Results for 2014 2Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 2
... applications support in plant ... ... (Nasdaq:,SIAL) and Metahelix Life Sciences today announced a partnership under ... product line, and provide expert technological guidance,regarding usage. The efforts ...
... Calif., July 8 Epeius Biotechnologies,Corporation today announced ... the U.S. Food and Drug Administration (FDA) for ... the rarity,seriousness, and current lack of effective therapies ... medicinal merit of Rexin-G, the,granting of Orphan Drug ...
... SCOTTSDALE, Ariz., July 8 MedPredict Market ... and market,research, has published a new report ... companies with a stake in the market ... report, entitled Thought Leader Insight & Analysis: ...
Cached Biology Technology:Sigma-Aldrich Announces Collaboration With Metahelix Life Sciences 2Sigma-Aldrich Announces Collaboration With Metahelix Life Sciences 3Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteosarcoma 2New MedPredict Report Highlights Trend Toward Early Diagnosis and Treatment of Rheumatoid Arthritis, Impact on Pharmaceutical Development 2
(Date:12/19/2014)... Research and Markets ( http://www.researchandmarkets.com/research/8kmfcn/iphone_5s ) has ... Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report" ... http://photos.prnewswire.com/prnh/20130307/600769 Following the acquisition of ... feature with the iPhone 5S. It is currently the ...
(Date:12/19/2014)... Inc., the leading personal genetics company, today announced the publication ... of individuals from across the United States ... hundred years ago, the United States ... continents. This study illuminates how American history and the ongoing ...
(Date:12/17/2014)... Markets ( http://www.researchandmarkets.com/research/s6qzt5/samsung_galaxy_s5 ) has announced the ... Button Synaptics Fingerprint Sensor Technology Analysis" report to ... Based on a totally different sensing technology ... time a fingerprint sensor in its product. ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2
... May 16, 2012 Cardium Therapeutics (NYSE Amex: CXM) ... Society of Gene & Cell Therapy (ASGCT) 15th Annual ... Convention Center in Philadelphia, PA. ... an important role in adenovector gene transfection (delivery) in ...
... SANTA CRUZ, CA--Researchers at the University of California, Santa Cruz, ... migrations of elephant seals have compiled one of the largest ... and diving behavior at sea in unprecedented detail. ... PLoS ONE focuses on the annual migrations of adult ...
... take on dangerous tasks every dayand starting this week, they will ... the Baltic Sea of underwater mines left over from as long ... will be among the biggest naval exercises in the Baltic Sea ... the two world wars. It,s all part of a day,s work ...
Cached Biology News:Delivery of gene-therapy for heart disease boosted 100-fold; now in 100-patient trial 2Elephant seal tracking reveals hidden lives of deep-diving animals 2Elephant seal tracking reveals hidden lives of deep-diving animals 3Undersea warriors, undersea medicine: The future force 2
Sheep polyclonal to Methaqualone ( Abpromise for all tested applications). Antigen: Methaqualone(5') conjugated to BSA...
... Product Goat polyclonal to BRF2 ... terminal amino acids 406-419 of Human BRF2. ... yet tested in other species. Background Information ... of the RNA polymerase III transcription factor complex ...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
alpha/beta-Tubulin Antibody Ship: Hot Store: -20 C...
Biology Products: